VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients

Angiogenesis

Volumn 15, Issue 2, 2012, Pages 265-273

  Peterson, Jon E ^a,b,c   Zurakowski, David ^b   Italiano Jr , Joseph E ^b,d   Michel, Lea V ^a,e   Connors, Susan ^b   Oenick, Marsha ^a   D'Amato, Robert J ^b   Klement, Giannoula L ^f   Folkman, Judah ^b  

^a Ortho Clinical Diagnostics Inc   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Salimetrics LLC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; PDGF; PF4; Platelets; Reference change value; VEGF

Indexed keywords

ACTIN; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CELL LEVEL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; STANDARDIZATION; THROMBOCYTE; THROMBOCYTE COUNT; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLATELET FACTOR 4; PLATELET-DERIVED GROWTH FACTOR; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865143174     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9259-z     Document Type: Article

References (30)

1. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932-936 (Pubitemid 43093958)
2. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273-287
3. Fuhrmann-Benzakein E, Ma MN, Rubbia-Brandt L et al (2000) Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int J Cancer 85:40-45
4. Nguyen M (1997) Angiogenic factors as tumor markers. Invest New Drugs 15:29-37 (Pubitemid 27217749)
5. Peterson JE, Zurakowski D, Italiano JE Jr et al (2010) Normal ranges of angiogenesis regulatory proteins in human platelets. Amer. J. Hematology 85:487-493
6. Klement GL, Kikuchi L, Kieran M (2004) Early tumor detection using platelet uptake of angiogenesis regulators. Blood 104 (abstr 839)
7. Klement GL, Yip T-T, Cassiola F et al (2009) Platelets actively sequester angiogenesis regulators. Blood 113:2835-2842
8. Saldago R, Benoy I, Bogers J et al (2001) Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 4:37-43 (Pubitemid 34032035)
9. Gonzalez FJ, Rueda A, Sevilla I et al (2004) Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation. Int J Biol Markers 19:221-228 (Pubitemid 39406244)
10. Hartwig JC (2008) The platelet cytoskeleton. In: Gresele P, Fuster V, López JA, Page CP, Vermylen J (eds) Platelets in hematologic and cardiovascular disorders. Cambridge University Press, New York, pp 75-97
11. Cervi D, Yip TT, Bhattacharya N et al (2008) Platelet-associated PF4 as a biomarker of early tumor growth. Blood 111:1201-1207 (Pubitemid 351213401)
12. Fraser CG (2001) Changes in serial results. In: Biological variation: from principals to practice. AACC Press, Washington, DC, pp 67-90
13. Grubbs F (1969) Procedures for detecting outlying observations in samples. Technometrics 11:1-21
14. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, Boca Raton, FL, pp 29-47
15. Pepe MS (2003) The statistical evaluation of medical tests for classification and prediction. Oxford University Press, New York, pp 66-95
16. Katz MH (2006) Multivariable analysis: a practical guide for clinicians, 2nd edn. Cambridge University Press, New York, pp 96-136
17. Zaslavsky A, Baek K-H, Lynch RC et al (2010) Platelet-derived thrombospondin-1 (TSP-1) is a critical negative regulator and potential biomarker of angiogenesis. Blood 115:4605-4613
18. Folkman J, Browder T, Palmblad J (2001) Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 86:23-33 (Pubitemid 32663933)
19. George ML, Eccles SA, Tutton MG, Abulafi M, Swift RI (2000) Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical Evidence of Platelet Scavenging? Clin Cancer Res 6:3147-3152 (Pubitemid 30637740)
20. Åkerblom B, Lindahl TL, Larsson A (2002) ADP activation induces bFGF binding to platelets in vitro. Upsala J Med Sci 107:165-171
21. Salgado R, Vermeulen PB, Benoy I et al (1999) Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients, Brit. J of Cancer 80:892-897 (Pubitemid 29209856)
22. Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61:46-52
23. Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9:1826-1830 (Pubitemid 26294751)
24. Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287-291 (Pubitemid 34298634)
25. Verheul HM, Hoekman K, Luykx-de Bakker S et al (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3:2187-2190 (Pubitemid 28133134)
26. Italiano JE Jr, Richardson JL, Patel-Hett S (2008) Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate alpha granules and differentially released. Blood 111:1227-1233 (Pubitemid 351213404)
27. Ma L, Perini R, McKnight W et al (2005) Proteinase activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102:216-220 (Pubitemid 40094455)
28. Ellis LM, Takahashi Y, Liu W, Shaheen R (2000) Vascular endothelial growth factor in human colon cancer: Biology and therapeutic implications. Oncologist 5(suppl 1):11-15 (Pubitemid 30225451)
29. Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49:407-424 (Pubitemid 28197463)
30. Lindmark G, Sundberg C, Glimelius B (1993) Stromal expression of platelet-derived growth factor beta-receptor and plateletderived growth factor B-chain in colorectal cancer. Lab Invest 69(6):682-689 (Pubitemid 24026849)